Clinical Trials · NCT00766857
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Amsterdam UMC, location VUmc
- Enrollment
- 27
- Start date
- May 2009
- Locations
- 1 site, Netherlands
- Primary endpoint
- Cardiac Magnetic Resonance (CMR) will be used to assess global cardiac function (LV ejection fraction).